Nicoletta Muner of Clinuvel Pharmaceuticals Ltd.
joined us for World Orphan Drug Congress USA 2015 to present about '
:Commercialization of a First-In-Class NCE'
Download her presentation now to understand more about:
Scenesse Clincial Program
Erythropoietic Protoporphyria (EPP)
EPP Clinical Development and Expanded Access
EMA Evaluation (Centralised Procedur)
Get your copy here!
To find out more about
World Orphan Drug Congress USA 2016 April 20-22
in Washington, DC.
Remember my details
Privacy statement »
Manage your email preferences »
You will be emailed the document as an attachment (645Kb in size)